Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc transporter YiiP, also known as FieF, is a bacterial membrane protein from Escherichia coli that belongs to the Cation Diffusion Facilitator (CDF) family [7, 24]. It functions as a homodimeric Zn2+/H+ antiporter, utilizing the proton motive force to export zinc, cadmium, and ferrous iron from the cytoplasm to the periplasm, thereby maintaining cellular metal homeostasis and preventing toxicity [4, 16, 27]. YiiP serves as a primary structural model for the human SLC30 (ZnT) family of transporters, which are critical for physiological processes such as insulin secretion and neurotransmission [7, 11]. Dysregulation of human homologs like ZnT8 is strongly associated with Type 2 Diabetes and neurodegenerative diseases, making these transporters significant therapeutic targets [18, 33]. The high-resolution structures of YiiP have elucidated the "rocking-bundle" mechanism of alternating access and the role of cytoplasmic sensing domains in allosteric regulation [6, 31, 33]. Consequently, YiiP serves as a vital template for structure-based drug discovery aimed at modulating zinc transport in various human pathologies [14, 30].
Zn2+/H+ antiport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc transporter YiiP (YiiP).